The Current Role of Long-Term Benzodiazepines for the Treatment of Generalized Anxiety

  • Steve Louvet, DO Aria Health, Langhorne PA
  • Michelle Ischayek, DO Aria Health, Langhorne PA
  • Rob Danoff, DO, MS, FACOFP, FAAFP Aria Health, Langhorne PA

Abstract

Benzodiazepines are one of the most widely used medications for the treatment of generalized anxiety. Due to their quick onset of action, efficacy and tolerability, benzodiazepines are widely prescribed by clinicians and utilized by patients. Although benzodiazepines have been beneficial and effective for the short-term management of anxiety, they have not been shown to be effective in producing long-term improvement. Chronic use of benzodiazepines has demonstrated multiple side effects including cognitive impairment, decreased motor coordination, concentration, social phobia, and depression. The development of tolerance, dependence and withdrawal are some of most significant problems associated with the long-term use of benzodiazepines. Withdrawal associated with the use of benzodiazepines includes insomnia, agitation, anxiety, seizures and coma.

Author Biographies

Steve Louvet, DO, Aria Health, Langhorne PA
Family Medicine
Michelle Ischayek, DO, Aria Health, Langhorne PA
Family Medicine
Rob Danoff, DO, MS, FACOFP, FAAFP, Aria Health, Langhorne PA
Family Medicine

References

Longo LP, Johnson B. Addiction: Part I. Benzodiazepines – Side Effects, Abuse Risk and Alternatives. Am Fam Physician. 2000 Apr 1; 61 (7): 2121-2128.

Fricchione G. Generalized Anxiety Disorder. N Engl J Med. 2004 Aug 12; 351: 675-82.

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC, American Psychiatric Association, 2013. pp. 189-233

Furukawa TA, Streiner DL, Young LT. Antidepressant and benzodiazepene for major depression. Cochrane Database Syst Rev 2002; 1: CD001026.

http://www.ncfahp.org/data/sites/1/media/images/pdf/Anxiety%20Algorithm.pdf, Downloaded 07/29/14

Shader R, Greenblatt D. Use of Benzodiazepines in Anxiety Disorders. New Engl J Med. 1993 May 13; Vol 328. No 19.

Sadock BJ, Sadock VA. Kaplan & Sadock’s Synopsis of Psychiatry, Tenth Edition. 2007. Lippincott Williams & Wilkins, Philadelphia, PA. pp 1018.

Virani AS, Bezchlibnyk-Butler K. Clinical Handbook of Psychotropic Drugs. 18th Edition. 2009. Hogrefe & Huber Publishers. pp 166-169.

Clinical Guideline 22 (amended). Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. National Institute for Health and Clinical Excellence. 2007. pp. 23–25. Retrieved 2009-08-08.

Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials. J. Psychopharmacol. Sep 2007. Oxford. 21(7): 774–82.

Lebellarte MJ, Ginsburg GS, Walkup JT, et al. The treatment of anxiety disorders in children and adolescents. Biol Psychiatry. 1999; 46 (11): 1567-1578.

Virani AS, Bezchlibnyk-Butler K. Clinical Handbook of Psychotropic Drugs. 18th Edition. 2009. Hogrefe & Huber Publishers. pp 163.

Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med. 1995; 55:1801–7.

K Sithamparanathanl MB BS CCFP, A Saderal. MD CCFP, L Leung1,2 MBBChir MFM(Clin) CCFP FRACGP FRCGP

Olivera J. Bogunovic, M.D.; Shelly F. Greenfield, M.D., M.P.H. Practical Geriatrics: Use of Benzodiazepines Among Elderly Patients. Psychiatric Services 2004; doi:10.1176/appi.ps.55.3.233

Grynpore RE, Mitenko PA, Sitar DS, et al: Drug-associated hospital admissions in older medical patients. Journal of the American Geriatrics Society 36:1092-1098, 1988.

Gray S, Lai K, Larson E: Drug-induced cognition disorders in the elderly. Drug Safety 21:101-122, 1999.

Cumming RG, Le Couter DG: Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 825-837, 2003.

Czeizel AE. 1988.Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Repod Toxicol 1:183-88.

Czeizel AE, Toth M. 1998. Birth weight, gestational age and medications during pregnancy. Int J Obstet Gynaecol Obstet 60:245-49.

Eros E, et al. 2002. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolam, and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 101:147-54.

Iqbal, Mohammad Masud M.D., M.P.H.; Tanveer Sobhan, M.D., M.P.H.; Thad Ryals, M.D. Effects of Commonly Used Benzodiazepines on the Fetus, the Neonate, and the Nursing Infant Psychiatric Services 2002; doi: 10.1176/appi.ps.53.1.39

McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol. 1994 Nov – Dec; 8 (6): 461-75.

Sadock BJ, Sadock VA. Kaplan & Sadock’s Synopsis of Psychiatry, Tenth Edition. 2007. Lippincott Williams & Wilkins, Philadelphia, PA. pp 1021.

Barker MJ. Cognitive Effects of Long-Term Benzodiazepine Use, A Meta-Analysis. School of Psychological Science, Original Research Article, University, Bundoora, Victoria, Australia.CNS Drugs 2004; 18 (1): 37-48.

Spiegel D, Bruce T. Benzodiazepines and Exposure-Based Cognitive Behavior Therapies for Panic Disorder: Conclusions from Combined Treatment Trials. Am J Psychiatry 1997; 154: 773-781.

Curran V. Memory functions, alertness, and mood of long-term benzodiazepine users: a preliminary investigation of the effects of normal daily dose. J Psychopharmacol. 1992; 6: 69-75.

Ashton H. Toxicity and adverse consequences of benzodiazepine use. Psychiatric Annals. 1995; 25: 158-65.

Kan CC, Breteler MH, Zitman FG: High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R andICD-10 criteria. Acta Psychiatr Scand 1997; 96: 85–93.

Virani AS, Bezchlibnyk-Butler K. Clinical Handbook of Psychotropic Drugs. 18th Edition. 2009. Hogrefe & Huber Publishers. pp 162.

Stewart SA. The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005; 66 (suppl 2): 9-13.

Nelson J, Chouinard G. Guidelines for the clinical use of benzodiazepines. Pharmacokinetics, dependency, rebound, and withdrawal. Can J Clin Pharmacol. 1999; 6(2): 69-83.

Virani AS, Bezchlibnyk-Butler K. Clinical Handbook of Psychotropic Drugs. 18th Edition. 2009. Hogrefe & Huber Publishers. pp 158-163.

Longo LP, Johnson B. Addiction: Part I. Benzodiazepines – Side Effects, Abuse Risk and Alternatives. Am Fam Physician. 2000 Apr 1; 61 (7): 2121-2128.

Virani AS, Bezchlibnyk-Butler K. Clinical Handbook of Psychotropic Drugs. 18th Edition. 2009. Hogrefe & Huber Publishers. pp 162.

Borkovec T, Ruscio A. Psychotherapy for Generalized Anxiety Disorder. J Clin Psychiatry. 2001; 62 (suppl 11): 37-38.

Published
2015-01-05
How to Cite
Louvet, DO, S., M. Ischayek, DO, and R. Danoff, DO, MS, FACOFP, FAAFP. “The Current Role of Long-Term Benzodiazepines for the Treatment of Generalized Anxiety”. Osteopathic Family Physician, Vol. 7, no. 1, Jan. 2015, https://ofpjournal.com/index.php/ofp/article/view/364.
Section
Review Articles